Quris
Quris-AI is a Bio-AI company building what it describes as pharma's first AI safety-prediction platform, aiming to predict which drug candidates will be safe in humans before they reach clinical trials. Its approach couples machine learning with "Patients-on-a-Chip" technology — miniaturized, organ-representative human tissue models that generate automatically-tagged biological data used to train classification algorithms for drug-safety prediction. The company targets the roughly 89% of drugs that fail in clinical trials, seeking to de-risk and accelerate pharmaceutical development. Based in Boston and Tel Aviv, Quris was co-founded with pioneers including Moderna co-founder Robert Langer and Nobel Laureate Aaron Ciechanover. Quris is backed by SoftBank Vision Fund and is profiled in the API Evangelist network as a company lead.
Quris is profiled on the APIs.io network. Tagged areas include Company, Health Tech, Bio-AI, Drug Discovery, and Drug Safety.
Quris’ developer surface includes engineering blog, support, and 4 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 1
Pricing, plans, and the legal terms of use
Company 3
The organization behind the API